Dr. Yaw Ampem Amoako

Senior Lecturer

Dept: Medicine
Department of Medicine
Ward D4,Komfo Anokye Teaching Hospital
Kumasi
Send quick mail

Research Areas/Interests

Internal Medicine Infectious Diseases and Tropical Medicine Neglected Tropical Diseases Non Communicable Diseases...~more

Profile Menu

Publications

     

    1. Amoako YA, Ackam N, Omuojine JP, Oppong MN, Owusu-Ansah AG, Abass MK, et al. Caregiver burden in Buruli ulcer disease: Evidence from Ghana. PLoS neglected tropical diseases. 2021;15(6):e0009454.
    2. Amoako YA, Loglo AD, Frimpong M, Agbavor B, Abass MK, Amofa G, et al. Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana. BMC infectious diseases. 2021;21(1):331. Epub 2021/04/10. doi: 10.1186/s12879-021-06009-7
    3. Frimpong M, Amoako Y, Anim K, Ahor H, Ye-Boah R, Arthur J, et al. Diagnostics for COVID-19: A case for field-deployable, rapid molecular tests for community surveillance. Ghana medical journal. 2020;54:71-6. doi: 10.4314/gmj.v54i4s.11.
    4. Amoako YA, Phillips RO, Arthur J, et al. A scabies outbreak in the North East Region of Ghana: The necessity for prompt intervention. PLoS neglected tropical diseases. 2020;14(12):e0008902
    5. Sylverken AA, El-Duah P, Owusu M, Schneider J, Yeboah R, Ayisi-Boateng NK,…Amoako YA, et al. Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing. Archives of virology. 2021:1-9. Epub 2021/03/17. doi: 10.1007/s00705-021-04986-3
    6. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. The British journal of surgery. 2021. Epub 2021/03/25. doi: 10.1093/bjs/znab101. PubMed PMID: 33761533; PubMed Central PMCID: PMCPMC7995808
    7. Phillips RO, Robert J, Abass KM, Thompson W, Sarfo FS, Wilson T, et al. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. Lancet (London, England). 2020;395(10232):1259-67. Epub 2020/03/17. doi: 10.1016/s0140-6736(20)30047-7
    8. Collinson S, Frimpong VNB, Agbavor B,…Amoako YA, et al. Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana. PLoS Negl Trop Dis. 2020;14(5):e0008369. Published 2020 May 26. doi:10.1371/journal.pntd.0008369
    9. Graßmann, S.; Pivovarova-Ramich, O.; Henze, A.; Raila, J.; Ampem Amoako, Y.; King Nyamekye, R.; Bedu-Addo, G.; Mockenhaupt, F.P.; Schulze, M.B.; Danquah, I. SNP rs6564851 in the BCO1 Gene Is Associated with Varying Provitamin a Plasma Concentrations but Not with Retinol Concentrations among Adolescents from Rural Ghana. Nutrients2020, 12, 1786.
    10. Amoako YA, Frimpong M, Awuah DO, et al. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports. Journal of medical case reports. 2019;13(1):218.
    11. Frimpong M, Agbavor B, Duah MS,...Amoako YA, et al. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load. PLoS neglected tropical diseases. 2019;13(8):e0007689.
    12. Amoako YA, Awuah B, Larsen-Reindorf R, et al. Malignant tumours in urban Ghana: evidence from the city of Kumasi. BMC cancer. 2019;19(1):267.
    13. Amoako YA, Hammond ENB, Assasie-Gyimah A, Laryea DO, Ankrah A, Amoah G. Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer. World journal of nuclear medicine. 2019;18(2):143.
    14. Amoako YA, Hammond EN, Assasie-Gyimah A, Sarfo-Kantanka O. Thyroid scintigraphy in the management of benign thyroid disease. Ghana medical journal. 2018;52(4):242-248.
    15. Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. The Pan African medical journal. 2014;18:274.
    16. Amoako YA, Laryea DO, Bedu-Addo G, Nkum BC, Plange-Rhule J. Left ventricular hypertrophy among chronic kidney disease patients in Ghana. Pan African Medical Journal. 2017;28:79.
    17. Bedu-Addo G, Ampem Amoako Y, Bates I. The role of bone marrow aspirate and trephine samples in haematological diagnoses in patients referred to a teaching hospital in Ghana. Ghana medical journal. 2013;47(2):74-78.
    18. Beissner M, Symank D, Phillips RO,...Amoako YA, et al. Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay. PLoS neglected tropical diseases. 2012;6(8):e1756.
    19. Danquah I, Bedu-Addo G, Terpe KJ,...Amoako YA, et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC public health. 2012;12:210.
    20. Danquah I, Dobrucky CL, Frank LK...Amoako YA, et al. Vitamin A: potential misclassification of vitamin A status among patients with type 2 diabetes and hypertension in urban Ghana. The American journal of clinical nutrition. 2015;102(1):207-214.
    21. Awittor FK, Amoako YA, Awuah B, Paintsil V, Osei-Tutu L, Laryea DO. A 4-Year Retrospective Analysis of Childhood Cancers in Kumasi, 2012-2015. Ghana Wkly Epidemiol Rep. 2018;3(2):5–10.
    22. Abubakar S, Amoako YA, Kotze T, Tag N. Source of Ectopic ACTH Secretion Easily Identified by 68 Ga DOTANOC PET/CT. Clinical nuclear medicine. 2017;42(4):295-296.
    23. Abubakar SO, Amoako YA, Tag N, Kotze T. False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography computed tomography. World journal of nuclear medicine. 2018;17(4):305.
    24. Amoako YA, Bedu-Addo G. Hyper-reactive malarial splenomegaly (HMS) in a patient with beta thalassaemia syndrome. The Pan African medical journal. 2014;19:310.
    25. Akinyemiju T, Abera S, Ahmed M, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA oncology. 2017.
    26. Laryea DO, Awuah B, Amoako YA, et al. Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC cancer. 2014;14:362.
    27. Phillips RO, Frimpong M, Sarfo FS, et al. Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana. Emerging infectious diseases. 2014;20(6):1000-1003.
    28. Phillips RO, Phanzu DM, Beissner M, et al. Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS neglected tropical diseases. 2015;9(1):e3457.
    29. Phillips RO, Sarfo FS, Abass MK, et al. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Antimicrobial agents and chemotherapy. 2014;58(2):1161-1166.
    30. Phillips RO, Sarfo FS, Abass MK, et al. Reply to "compliance with antimicrobial therapy for buruli ulcer". Antimicrobial agents and chemotherapy. 2014;58(10):6341.
    31. Sarfo FS, Le Chevalier F, Aka N, et al. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring. PLoS neglected tropical diseases. 2011;5(7):e1237.
    32. Sarfo FS, Phillips RO, Zhang J, et al. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease. BMC infectious diseases. 2014;14:202.
    33. Fitzmaurice C, Allen C, Barber RM, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology. 2017;3(4):524-548.
    34. Hammond ENB, Amoako YA, Vangu MWH. Oral lithium as an adjunctive therapy during radioiodine treatment for hyperthyroidism. Nuclear medicine communications. 2017;38(12):1133.
    35. Kollie K, Amoako YA, Ake J, et al. Buruli ulcer in Liberia, 2012. Emerging infectious diseases. 2014;20(3):494-496.
    36. Laryea DO, Amoako Y, Armooh DV, Abbeyquaye EP, Amartey BN. The Threat of Ebola Virus Disease: a Call to Integrate all Sectors in Surveillance Activities in Ghana. Online journal of public health informatics. 2015;7(1).
    37. Laryea DO, Amoako YA, Asamoah J. Antibiotic Sensitivity and Clinical Outcome for Methicillin Resistant Staphylococcus Aureus. Online journal of public health informatics. 2014;6(1).
    38. Laryea DO, Amoako YA, Spangenberg K, Frimpong E, Kyei-Ansong J. Contraceptive use and unmet need for family planning among HIV positive women on antiretroviral therapy in Kumasi, Ghana. BMC women's health. 2014;14:126.
    39. Laryea DO, Ankobeah F, Morhe ESK, Amoako YA, Spangenberg K. Characteristics and contributory factors for injectable contraceptive usage among women in Kumasi, Ghana. Contracept Reprod Med. 2016;1:8.
    40. Laryea DO, Awuah B, Amoako YA, Mensah S, Awittor FK. Follow-up of Breast Cancer Patients in Ghana: Challenges to Community-based Surveillance. Online journal of public health informatics. 2015;7(1).
    41. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet (London, England). 2017;390(10091):231-266.
    42. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1345-1422.
    43. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1260-1344.
    44. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1211-1259.
    45. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1084-1150.
    46. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1151-1210.
    47. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory medicine. 2017;5(9):691-706.
    48. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious diseases. 2018.
    49. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2018;392(10152):1015-1035.
    50. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet (London, England). 2018;391(10136):2236-2271.
    51. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018;392(10159):1859-1922.

Related Profiles

Print page

SEND QUICK MAIL TO STAFF

Subject

Message

Your Email Address:
Note: this is to help the staff contact you back.